The week in health tech, explained in plain English.Get the free newsletter →
October 4, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Provider-Sponsored Health Plans Face a Survival Test

Health systems have long chased the promise of owning their own insurance plans: capture the premium dollar, coordinate care, and control costs end to end. In 2026, that bet is looking shakier for several of them.

Renton, Wash.-based Providence is slated to close most of its insurance business, Providence Health Plan, starting in 2027, according to Becker's Hospital Review. It follows recent wind-downs by Urbana, Ill.-based Carle Health and Ann Arbor-based Michigan Medicine. The common thread is that running a health plan demands actuarial expertise, capital reserves, and enrollment scale that many providers underestimated.

Not every provider-sponsored plan is retreating, Becker's notes, and larger, well-capitalized systems continue to operate profitable insurance arms. The lesson is that vertical integration only pays off when a system can absorb insurance risk and reach enough members to spread it. For systems weighing the same move, the recent closures are a warning that the payer business rewards scale and discipline over ambition alone.

More in Payers

Payers

7 Health System Insurers to Exit Medicare Advantage in 2027

Seven health system-owned insurers are among 11 health plans exiting the individual Medicare Advantage market in 2027, with several others narrowing to special needs plans only.

Why it matters: The exits signal that even provider-owned plans are struggling with Medicare Advantage economics, forcing seniors to find new coverage.

Payers

CMS Projects Lower MA Premiums, Flat Enrollment for 2027

CMS projects lower average Medicare Advantage premiums and flat enrollment of 34 million for 2027, a figure that already trails current membership of 36.1 million.

Why it matters: Medicare Advantage now covers nearly half of all Medicare enrollees, so its premium and growth trajectory shapes revenue for insurers, providers, and the federal budget.

Payers

PBMs Become Rare Bipartisan Target in Washington and States

A bipartisan push in Congress and statehouses aims to rein in pharmacy benefit managers, including proposals to force CVS and rivals to split their PBM and pharmacy businesses.

Why it matters: PBMs sit at the center of US drug pricing, and forced divestiture would upend the business models of the largest healthcare conglomerates.